Kestra Medical Technologies, LTD. 8-K Filing

FAQ

Key Financial Figures

• $1.00 — ch registered Common Shares, par value $1.00 per share KMTS The Nasdaq Stock Mar

Filing Documents

• d944376d8k.htm (8-K) — 29KB
• d944376dex991.htm (EX-99.1) — 11KB
• g944376g56h28.jpg (GRAPHIC) — 4KB
• 0001193125-25-303104.txt ( ) — 170KB
• kmts-20251201.xsd (EX-101.SCH) — 3KB
• kmts-20251201_lab.xml (EX-101.LAB) — 19KB
• kmts-20251201_pre.xml (EX-101.PRE) — 12KB
• d944376d8k_htm.xml (XML) — 4KB

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K and the materials furnished herewith contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about, among other topics, the Company's preliminary estimated financial results for the fiscal quarter ended October 31, 2025, which are preliminary unaudited estimates that are subject to significant uncertainties. Any statements in this Current Report on Form 8-K and the materials furnished herewith that express a belief, expectation or intention, as well as those that are not historical fact, are forward-looking statements. You can also identify these statements by the fact that they use future dates or use words such as "will," "may," "could," "likely," "ongoing," "anticipate," "estimate," "expect," "project," "intend," "plan," "believe," "assume," "target," "forecast," "guidance," "goal," "objective," "aim," "seek," "potential," "hope" and other words and terms of similar meaning. All information in this Current Report on Form 8-K is as of the Date of Report indicated above. Except as required by law, the Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Given their forward-looking nature, these statements involve substantial risks, uncertainties and potentially inaccurate assumptions, and there is no assurance that any outcome expressed in these forward-looking statements will be realized in whole or in part. Among the factors that could cause actual results to differ materially from past results and future plans and projected future results are the following: risks related to the Company's limited operating history and history of net losses; the Company's ability to successfully achieve substantial market adoption of the Company's products; competitive pressures; the Company's ability to adapt the Company's manufacturing and product

Financial Statements and Exhibits

Financial Statements and Exhibits. Exhibit Number Description 99.1 Press Release of Kestra Medical Technologies, Ltd., dated December 1, 2025 104 Cover Page Interactive Data File, formatted in Inline XBRL.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Kestra Medical Technologies, Ltd. Date: December 1, 2025 By: /s/ Brian Webster Name: Title: Brian Webster President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR